XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles - Restricted Cash and Restricted Investments (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds   $ 88,662    
Current restricted cash $ 25,057 75,685    
Total current restricted cash and restricted investments 25,057 75,685    
Non-current restricted cash 13,005 12,977    
Total non-current restricted cash and restricted investments 13,005 12,977    
Cash and cash equivalents 156,756   $ 252,496  
Restricted cash and restricted investments 38,062   29,259  
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows [1] 194,818 354,942 $ 281,755 $ 361,581
Collateral for letters of credit for facility leases        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 2,269 3,769    
Collateral with financial institutions        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 10,873 11,662    
Claims processing services        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 24,904 73,226    
Other        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds $ 16 $ 5    
[1] As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the nine months ended September 30, 2021. See Note 5.